Phibro Animal Health (FRA:PB8) Construction In Progress : €0.0 Mil (As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Phibro Animal Health Construction In Progress?

Phibro Animal Health's annual construction in progress increased from Jun. 2021 (€19.6 Mil) to Jun. 2022 (€29.0 Mil) and increased from Jun. 2022 (€29.0 Mil) to Jun. 2023 (€32.1 Mil).

Phibro Animal Health Construction In Progress Historical Data

The historical data trend for Phibro Animal Health's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Phibro Animal Health Construction In Progress Chart

Phibro Animal Health Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Construction In Progress

Get a 7-Day Free Trial

19.64

28.99

32.07

Phibro Animal Health Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Construction In Progress	Get a 7-Day Free Trial															-	32.07	-	-	-

Phibro Animal Health Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

Phibro Animal Health (FRA:PB8) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Phibro Animal Health Corp (FRA:PB8) » Definitions » Construction In Progress

Comparable Companies

Traded in Other Exchanges

PAHC:USA

Address

300 Frank W. Burr Boulevard, Suite 21, 3rd Floor, Glenpointe Centre East, Teaneck, NJ, USA, 07666-6712

Website

https://www.pahc.com

Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.

Phibro Animal Health (FRA:PB8) Headlines

No Headlines